Genome-based and transcriptome-based molecular classification of breast cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Opinion in Oncology

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CCO.0b013e3283412ee0PMID 21076301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved classification of breast cancer by analysis of genetic alterations and gene expression profiling

  2011cited by this paper
• Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft

  2010cited by this paper
• Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.

  2010cited by this paper
• The landscape of somatic copy-number alteration across human cancers

  2010cited by this paper
• Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

  2010cited by this paper
• MicroRNAs and their target gene networks in breast cancer

  2010cited by this paper
• Direct detection of DNA methylation during single-molecule, real-time sequencing

  2010cited by this paper
• Genome-wide association study identifies five new breast cancer susceptibility loci

  2010cited by this paper
• Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

  2010cited by this paper
• International network of cancer genome projects

  2010cited by this paper
• Mouse mammary tumor virus-like sequences in human breast cancer.

  2010cited by this paper
• Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

  2010cited by this paper
• Extending the frontiers of epigenetic regulation.

  2010cited by this paper
• International Network of Cancer Genome Projects

  2010cited by this paper
• High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast

  2010cited by this paper
• Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.

  2009cited by this paper
• Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line

  2009cited by this paper
• AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist

  2009cited by this paper
• Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum

  2009cited by this paper
• A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer.

  2009cited by this paper
• Confounding effects in "a six-gene signature predicting breast cancer lung metastasis": reply.

  2009cited by this paper
• COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES

  2009cited by this paper
• Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

  2009cited by this paper
• Long non-coding RNAs: insights into functions

  2009cited by this paper
• Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.

  2009cited by this paper
• Evolution and functions of long noncoding RNAs.

  2009cited by this paper
• Commonality but diversity in cancer gene fusions.

  2009cited by this paper
• A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome.

  2009cited by this paper
• Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.

  2008cited by this paper
• Epigenomics and breast cancer.

  2008cited by this paper
• A six-gene signature predicting breast cancer lung metastasis.

  2008cited by this paper
• Subtypes of breast cancer show preferential site of relapse.

  2008cited by this paper
• Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase inhibitor NVP-BEZ235.

  2008cited by this paper
• Genome analysis of the platypus reveals unique signatures of evolution

  2008cited by this paper
• Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors

  2008cited by this paper
• PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer

  2008cited by this paper
• Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers

  2008cited by this paper
• Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF.

  2007cited by this paper
• Chromosome 5q deletion and epigenetic suppression of the gene encoding α-catenin (CTNNA1) in myeloid cell transformation

  2007cited by this paper
• MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

  2007cited by this paper
• High-throughput oncogene mutation profiling in human cancer

  2007cited by this paper
• The Genomic Landscapes of Human Breast and Colorectal Cancers

  2007cited by this paper
• Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer

  2007cited by this paper
• A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

  2007cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

  2006cited by this paper
• The Consensus Coding Sequences of Human Breast and Colorectal Cancers

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer

  2005cited by this paper
• Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry.

  2005cited by this paper
• PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.

  2005cited by this paper
• Mutant PIK3CA promotes cell growth and invasion of human cancer cells.

  2005cited by this paper
• Mutation of GATA3 in human breast tumors

  2004cited by this paper
• Use of High-Throughput Protein Array for Profiling of Differentially Expressed Proteins in Normal and Malignant Breast Tissue

  2004cited by this paper
• Quantitation of HERV-K env gene expression and splicing in human breast cancer

  2003cited by this paper
• AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.

  2003cited by this paper
• Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.

  2002cited by this paper
• Identification of a proviral structure in human breast cancer.

  2001cited by this paper
• MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Molecular cytogenetics of primary breast cancer by CGH

  1998cited by this paper
• E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.

  1996cited by this paper
• Detection of mammary tumor virus env gene-like sequences in human breast cancer.

  1995cited by this paper

• 3'-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of immunogenic cell death in triple-negative breast cancer cells.

  2022cites this paper
• HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation

  2021cites this paper
• HDAC6 Inhibitors Sensitize Claudin-high Breast Cancer Cells to Cysteine Depletion via Activation of PKCγ Signaling

  2020cites this paper
• The arrow of carcinogenesis

  2018cites this paper
• Hubungan Polimorfisme Gen Reseptor Vitamin D BSM-1 dengan Kadar Plasma Vitamin D pada Kanker Payudara

  2018cites this paper
• ABCB 1-C 3435 T polymorphism and breast cancer risk : a case-control study and a meta-analysis

  2017cites this paper
• Deciphering the molecular signaling pathways in breast cancer pathogenesis and their role in diagnostic and treatment modalities

  2017cites this paper
• ABCB1-C3435T polymorphism and breast cancer risk: a case-control study and a meta-analysis.

  2016cites this paper
• Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer.

  2016cites this paper
• C / T and 3435 C / T polymorphisms of the ABCB 1 gene in Mexican breast cancer patients

  2015influential citation
• 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients.

  2015cites this paper
• Molecular-Based Diagnostic, Prognostic and Predictive Tests in Breast Cancer

  2015cites this paper
• Specimens for Molecular Testing in Breast Cancer

  2015cites this paper
• Identification of ApoA1, HPX and POTEE genes by omic analysis in breast cancer.

  2014cites this paper
• Theranostic and molecular classification of breast cancer.

  2014cites this paper
• Inferring tumor evolution using computational phylogenetics

  2013influential citation
• Breast Cancer Genomics: From Portraits to Landscapes

  2013cites this paper
• Molecular profiling: an essential technology enabling personalized medicine in breast cancer.

  2012cites this paper
• Integrated Proteomic, Transcriptomic, and Biological Network Analysis of Breast Carcinoma Reveals Molecular Features of Tumorigenesis and Clinical Relapse*

  2012cites this paper
• Modulation of Epigenetic Targets for Anticancer Therapy: Clinicopathological Relevance, Structural Data and Drug Discovery Perspectives

  2012cites this paper
• Breast Cancer from Molecular Point of View: Pathogenesis and Biomarkers

  2011cites this paper
• Chromatin Profiles of Human Cells in Health and Disease Using FAIRE

  2011cites this paper
• Estrogen sulfotransferase (sult1e1) expression and function in mcf10a-series breast epithelial cells: role as a modifier of breast carcinogenesis and regulation by proliferation state

  2011cites this paper
• "Introducing ER in ER-negative breast cell lines does not reproduce a prototypical transcriptomic response to estrogens, or ER cistromes."

  2011cites this paper
• Are 'omics of estrogen receptors defining potential targets for breast cancer treatment?

  2011cites this paper
• Inference of Tumor Phylogenies from Genomic Assays on Heterogeneous Samples

  2011cites this paper